Back
Louisiana-Pacific 10K Form
Buy
56
LPX
Louisiana-Pacific
Last Price:
114.47
Seasonality Move:
13.94%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-08 | 10Q | LPX/Louisiana-Pacific Quarterly |
2023-11-01 | 10Q | LPX/Louisiana-Pacific Quarterly |
2023-08-02 | 10Q | LPX/Louisiana-Pacific Quarterly |
2023-05-03 | 10Q | LPX/Louisiana-Pacific Quarterly |
2022-11-03 | 10Q | LPX/Louisiana-Pacific Quarterly |
2022-08-09 | 10Q | LPX/Louisiana-Pacific Quarterly |
Receive LPX News And Ratings
See the #1 stock for the next 7 days that we like better than LPX
LPX Financial Statistics
Sales & Book Value
Annual Sales: | $2.58B |
---|---|
Cash Flow: | $139M |
Price / Cash Flow: | 17.45 |
Annual Sales: | $23.71 |
Price / Book: | 4.86 |
Profitability
EPS (TTM): | 5.80000 |
---|---|
Net Income (TTM): | $417M |
Gross Margin: | $593M |
Return on Equity: | 26.06% |
Return on Assets: | 16.8% |
Louisiana-Pacific Earnings Forecast
Key Louisiana-Pacific Financial Ratios
- The Gross Profit Margin over the past 40 years for LPX is 22.98%.
- The Selling, General & Administrative Expenses for LPX have been equal to 9.96% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 7.30% of Operating Income.
- The Net Earning history of LPX is 6.90% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 23 years.
Louisiana-Pacific Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Paper & Forest Products |
Sector: | Materials |
Current Symbol: | LPX |
CUSIP: | 546347 |
Website: | lpcorp.com |
Debt
Debt-to-Equity Ratio: | 0.21 |
---|---|
Current Ratio: | 2.91 |
Quick Ratio: | 1.59 |
Price-to-Earnings
Trailing P/E Ratio: | 46.86 |
---|---|
Forward P/E Ratio: | 20.91 |
LPX Technical Analysis vs Fundamental Analysis
Buy
56
Louisiana-Pacific (LPX)
is a Buy
Is Louisiana-Pacific a Buy or a Sell?
-
Louisiana-Pacific stock is rated a Buy
The current Louisiana-Pacific [LPX] share price is $111.39. The Score for LPX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.